These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 239828)

  • 1. The cause of death of Palaemonetes varians (Leach, 1814) treated with cholinesterase inhibitors.
    Koning LJ; van der Meer C
    Comp Biochem Physiol C Comp Pharmacol; 1975 Jun; 51(1):73-7. PubMed ID: 239828
    [No Abstract]   [Full Text] [Related]  

  • 2. On the development of behavioral tolerance to organophosphates. III: Behavioral aspects.
    Wolthuis OL; Philippens IH; Vanwersch R
    Pharmacol Biochem Behav; 1990 Mar; 35(3):561-5. PubMed ID: 2339148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of soman and DFP in vivo and in vitro on cerebral metabolism in the rat.
    Jović R; Bachelard HS; Clark AG; Nicholas PC
    Biochem Pharmacol; 1971 Mar; 20(3):519-27. PubMed ID: 4260787
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of physostigmine, paraoxon and soman on brain GABA level and metabolism.
    Coudray-Lucas C; Prioux-Guyonneau M; Sentenac H; Cohen Y; Wepierre J
    Acta Pharmacol Toxicol (Copenh); 1984 Aug; 55(2):153-7. PubMed ID: 6496115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Action of acetylcholine in the presence of organophosphates on single axons of the lobster.
    Bartels E; Brzin M; Dettbarn WD
    Biochem Pharmacol; 1969 Oct; 18(10):2590-5. PubMed ID: 5404568
    [No Abstract]   [Full Text] [Related]  

  • 6. Dissociation of locomotor depression and ChE activity after DFP, soman and sarin.
    Lynch MR; Rice MA; Robinson SE
    Pharmacol Biochem Behav; 1986 Apr; 24(4):941-7. PubMed ID: 3714785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylcholinesterases of organophosphate-susceptible and -resistant spider mites.
    Smissaert HR; Voerman S; Oostenbrugge L; Renooy N
    J Agric Food Chem; 1970; 18(1):66-75. PubMed ID: 5524466
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of cholinesterases of rat diaphragm muscle by organophosphates and spontaneous recovery of enzyme activity in vitro.
    Welsch F; Dettbarn WD
    Biochem Pharmacol; 1972 Apr; 21(7):1039-49. PubMed ID: 5039748
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative study of the effects of selective inhibitors on esterase isozymes from the mosquito Anopheles punctipennis.
    Booth GM; Connor J; Metcalf RA; Larsen JR
    Comp Biochem Physiol B; 1973 Apr; 44(4):1185-95. PubMed ID: 4123528
    [No Abstract]   [Full Text] [Related]  

  • 10. Pseudocholinesterases of mammalian plasma: physicochemical properties and organophosphate inhibition in eleven species.
    Ecobichon DJ; Comeau AM
    Toxicol Appl Pharmacol; 1973 Jan; 24(1):92-100. PubMed ID: 4631366
    [No Abstract]   [Full Text] [Related]  

  • 11. Histamine release by esterase inhibitors. The regulation of histamine release from human leukocytes of allergic and non-allergic individuals by the serine esterase inhibitors diisopropyl fluorophosphate and pinacolyl methylphosphorofluoridate.
    Meier HL; Gross CL; Papirmeister B; Kagey-Sobotka A; Kilduff JE
    Int Arch Allergy Appl Immunol; 1985; 77(1-2):218-21. PubMed ID: 2409020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated choline levels in brain. A non-cholinergic component of organophosphate toxicity.
    Flynn CJ; Wecker L
    Biochem Pharmacol; 1986 Sep; 35(18):3115-21. PubMed ID: 3753519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of rat brain 5-hydroxytryptamine metabolism by sublethal doses of organophosphate agents.
    Prioux-Guyonneau M; Coudray-Lucas C; Coq HM; Cohen Y; Wepierre J
    Acta Pharmacol Toxicol (Copenh); 1982 Oct; 51(4):278-84. PubMed ID: 6184944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The protective effects of ethylestrenol against acute poisoning by organophosphorus cholinesterase inhibitors in rats.
    Robinson CP; Smith PW; Crane CR; McConnell JK; Allen LV; Endecott BR
    Arch Int Pharmacodyn Ther; 1978 Jan; 231(1):168-76. PubMed ID: 637620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Different effects of organophosphorus compounds Paraoxon and Soman on the discharge rate in single fibers of the rat phrenic nerve].
    Sakai Y; Ri H dal ; Schmidt G
    Arch Toxikol; 1973; 30(2):147-59. PubMed ID: 4685265
    [No Abstract]   [Full Text] [Related]  

  • 16. Atropine-insensitive vasodilatation and hypotension in the organophosphate-poisoned rabbit.
    Preston E; Heath C
    Arch Int Pharmacodyn Ther; 1972 Dec; 200(2):231-44. PubMed ID: 4645866
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin.
    Davies HG; Richter RJ; Keifer M; Broomfield CA; Sowalla J; Furlong CE
    Nat Genet; 1996 Nov; 14(3):334-6. PubMed ID: 8896566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organophosphorus anticholinesterases do not mediate analgesia through inhibition of enkephalin degradation.
    Marchner H; Haraldsson S; Lundberg S
    Life Sci; 1986 Apr; 38(14):1317-21. PubMed ID: 3515093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of the molar concentration of acetylcholinesterase based on phosphorylation by paraoxon or soman].
    Nenner M
    Biochim Biophys Acta; 1971 Aug; 242(2):371-80. PubMed ID: 5160151
    [No Abstract]   [Full Text] [Related]  

  • 20. Cerebral metabolic effects of organophosphorus anticholinesterase compounds.
    Miller AL; Medina MA
    Metab Brain Dis; 1986 Jun; 1(2):147-56. PubMed ID: 3508239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.